The Yield Lab Asia Pacific — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Aptimmune Biologicsaptimmune.com𝕏Jun 2017Acquired
Aptimmune develops vaccines for swine health, partnering with vaccine development and swine health consulting companies to speed product development, testing and manufacturing.
AgTechBiotechHealthtechChampaign, US
Aaron Gilbertie(CEO)Federico Zuckermann(Executive Officer, Director)
BoardRobert Easter(Director)Paul Olivo(Director)Gary Durack(Director)
Co-investorsMissouri Technology CorporationArsenalCultivation CapitalThe Yield LabIllinois Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.